People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Business Services, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Impactrx Inc | — | Business Services | Seed | $1.9M | $30.5M | 2009 |
| Visen Medical Inc | — | Biotechnology | Pre-Seed | $885K | $48.9M | 2009 |
Per G. H. Lofberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Per G. H. Lofberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ed Kania | 1 | 3 |
| Lawrence G. Miller, M.D. | 1 | 1 |
| Renee G. Aguiar-Lucander | 1 | 1 |
| Richard Altus | 1 | 1 |
| Ralph G. H. Weissleder, Ph.D. | 1 | 1 |
| Erik G. H. Wallden | 1 | 1 |
| John G. H. Ziolkowski | 1 | 1 |
| Kirtland G. H. Poss | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.